Pharmacology Corner

Articles related to ‘Hematology, cancer chemotherapy and related’

• Animation showing the Jak-Stat signalling pathway mechanism

  6/12/10 • (2)

• 

  COGENT trial: no clopidogrel-PPIs interaction

  10/26/09 • (0)

• 

  Cancer chemotherapy: PPT presentations

  9/27/09 • (5)

• 

  Serotonin 5-HT3-receptor antagonists: pharmacokinetics, MOA, indications and adverse effects

  8/25/09 • (5)

• FDA video on erlotinib (Tarceva) adverse effects

  7/29/09 • (1)

• 

  Rituximab (Rituxan, MabThera): first line treatment for chronic lymphocytic leukemia

  7/22/09 • (0)

• 

  PPIs reduce the effectiveness of clopidogrel (Plavix)

  7/10/09 • (0)

• 

  Thrombolytic agents: mechanism of action, indications, contraindications and side effects

  6/02/09 • (1)

• 

  FDA approves bevacizumab (Avastin) for glioblastoma multiforme

  5/09/09 • (1)

• 

  Overview on monoclonal antibody therapy: PPT, images and videos

  5/06/09 • (10)

• Lectures on antiemetics pharmacology: MOA, indications, side effects and new drugs reviewed

  4/01/09 • (0)

• NICE recommends sunitinib (Sutent) for the first-line treatment of metastatic renal cancer

  3/26/09 • (0)

• Warfarin dosing: the role of genes

  3/25/09 • (0)

• Vorinostat MSD for cutaneous T-cell lymphoma. MSD withdraws marketing application

  2/17/09 • (0)

© 2010 • Continuing medical education in clinical Pharmacology and Therapeutics | Pharmamotion | Powered by WordPress & Mimbo

Blog Entries • Comments